← All indications
Osteoporosis, Postmenopausal
Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
Drugs by status
Approved for this indication (10)
Phase 4 trials (19)
Phase 3 trials (9)
Phase 2 trials (9)
Phase 1 trials (8)
Other trials (23)
- maltodextrin
- norgestrel
- dehydroepiandrosterone
- Hesperedin
- drospirenone
- cow milk
- bifidobacterium bifidum
- moringa oleifera
- p-inulin
- prunus domestica
- calcilock
- corn
- prune
- methandrostenolone
- quercetin
- Lactobacillus acidophilus
- lactobacillus casei
- lactobacillus reuteri
- lactobacillus rhamnosus
- strontium l-lactate
- magnesium stearate
- 24,25-dihydroxycholecalciferol
- Asparagus racemosus
Organizations
Organization Involved with Phase 4 Indications (24)
- Radius Health
- Amgen
- Merck
- Sanofi
- Sanofi-Aventis
- Bio Sidus SA
- GlaxoSmithKline
- Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
- National Institutes of Health (NIH)
- National Institute on Aging (NIA)
- Hellenic Army
- University of Pittsburgh
- Cornell University
- Harvard University
- Instituto Palacios
- Ondokuz Mayıs University
- University of Alberta
- University of Valencia
- Tsinghua University
- Medical University of Vienna
- Crozer Chester Medical Center, Pennsylvania
- Humboldt University
- Department of Veteran Affairs
- Osteoporosis Center of Delaware County
Organization Involved with Phase 3 Indications (15)
- Eisai
- Shire
- Chiesi
- Qilu Pharmaceutical Co., Ltd.
- Tarsa Therapeutics, Inc.
- Warner Chilcott
- University of London
- University of Toronto
- Jiao Tong University
- Bethesda Health Research Center
- Canadian Institutes of Health Research (CIHR)
- Samsung
- Shanghai Biomabs Pharmaceuticals Co Ltd
- University of Helsinki
- Chinese Academy of Medical Sciences
Organization Involved with Phase 2 Indications (17)
- Ligand Pharmaceuticals
- Wyeth
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Unigene Laboratories Inc.
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Emory University
- Helen Hayes Hospital
- Sheffield Hallam University
- Columbia University
- Fujian Academy of Traditional Chinese Medicine
- Soochow University
- University of California, Irvine
- Department of Defense
- Nordic Bioscience
- CCBR Clinical Research
- Osteoporosis Center of Armenia
Organization Involved with Phase 1 Indications (12)
Organization Involved with Other Experimental Indications (18)
- BioGaia AB
- Appalachian State University
- Postgraduate Institute of Medical Education and Research
- University of Limerick
- University of Chicago
- University of Colorado, Denver
- Biofortis
- Pennsylvania State University
- University of Sao Paulo
- University of Gothenburg
- Aristotle University of Thessaloniki
- North Carolina Agricultural and Technical State University
- California Dried Plum Board
- Tate & Lyle
- Nestle
- BioLink Life Sciences, Inc.
- NMS Laboratories
- Dairygold Cooperative Society